Sign In
Buy IHE
$90.02
+1.03 (+1.16%)
At Close: Jun 03, 2026
A Look at Pharma ETFs After Strong Q1 Earnings
12:50pm, Thursday, 08'th May 2025
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:20am, Monday, 28'th Apr 2025
Launched on 05/01/2006, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity mar
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:20am, Monday, 24'th Feb 2025
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on
ETFs Poised to Win or Lose Under Trump's New Policies
11:11am, Tuesday, 21'st Jan 2025
Donald Trump commences his second term by enacting a series of executive orders. The actions are poised to create winners and losers across different industries.
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs
07:05am, Friday, 17'th Jan 2025
For many of us, a new year often means a new chance to start fresh in our battle with weight. Thanks to interesting ETF product development, especially in the past year, it could also mean a chance to
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Monday, 23'rd Dec 2024
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on
IHE Contraction Is Not Justified By Fundamental Data
09:30pm, Thursday, 21'st Nov 2024
iShares U.S. Pharmaceuticals ETF is a pharmaceutical ETF offered by iShares, featuring an expense ratio of 0.39% and over $500 million in assets under management. In Q3, the healthcare sector reported
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:20am, Monday, 21'st Oct 2024
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fun
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Tuesday, 20'th Aug 2024
Launched on 05/01/2006, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity mar
Pharma ETFs in Focus Post Solid Q2 Earnings
12:51pm, Wednesday, 14'th Aug 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Disruptive Theme of the Week: Playing Defense
08:39am, Wednesday, 14'th Aug 2024
When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.
IHE: Significant Growth Ahead, But Valuation Not Cheap (Rating Downgrade)
11:07pm, Wednesday, 24'th Jul 2024
IHE invests in large-cap U.S. pharmaceutical stocks with solid long-term growth outlook but high concentration risk. IHE's fund price has been steady with a positive trend in 2024, but its elevated va
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:20am, Tuesday, 18'th Jun 2024
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on
A Look at Pharma ETFs Post Q1 Earnings
12:31pm, Tuesday, 07'th May 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Why investor appetite for commodity funds picked up despite ETF flows broadly seeing ‘pretty big drop' in April
04:28pm, Thursday, 02'nd May 2024
Hello! This week's ETF Wrap digs into the slump in ETF flows in April and investor positioning around commodities as inflation worries persist.
